TMCI Treace Medical Concepts Inc
- Stocks
- Healthcare
- NASDAQ: TMCI
Price (delayed)
$6.25
Market cap
$394.83M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.79
Enterprise value
$453.67M
Relative Growth:
Rel. Growth:
56
Relative Strength:
Rel. Strength:
38
Relative Valuation:
Rel. Valuation:
22
Relative Profitability:
Rel. Profitability:
36
Based in Ponte Vedra, FL, Treace Medical Concepts, Inc. is a privately-held medical device company focused on advancing the standard of care for the surgical management of bunion deformities. The
Highlights
The company's net income rose by 23% YoY and by 7% QoQ
The EPS is up by 23% year-on-year and by 7% since the previous quarter
Treace Medical Concepts's quick ratio has decreased by 26% QoQ and by 12% YoY
The equity has declined by 13% year-on-year and by 7% since the previous quarter
Key stats
What are the main financial stats of TMCI
Market
Valuations
Earnings
Shares outstanding
63.17M
Market cap
$394.83M
Enterprise value
$453.67M
Price to earnings (P/E)
N/A
Price to book (P/B)
4.03
Price to sales (P/S)
1.84
PEG
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.12
Revenue
$213.75M
Gross profit
$171.25M
Operating income
-$47.89M
Net income
-$49.18M
EBIT
-$43.92M
EBITDA
-$32.19M
Free cash flow
-$29.15M
Per share
Balance sheet
Liquidity
EPS
-$0.79
EPS diluted
-$0.79
Free cash flow per share
-$0.46
Book value per share
$1.55
Revenue per share
$3.39
TBVPS
$2.95
Total assets
$206.44M
Total liabilities
$108.83M
Debt
$66.89M
Equity
$97.62M
Working capital
$105.7M
Debt to equity
0.69
Current ratio
3.52
Quick ratio
2.38
Net debt/EBITDA
-1.83
Margins
Efficiency
Dividend
EBITDA margin
-15.1%
Gross margin
80.1%
Net margin
-23%
Operating margin
-22.4%
Return on assets
-23.4%
Return on equity
-46.8%
Return on invested capital
-20.9%
Return on capital employed
-26.7%
Return on sales
-20.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TMCI stock price
How has the Treace Medical Concepts stock price performed over time
Intraday
-4.14%
1 week
-4.58%
1 month
-1.73%
1 year
8.51%
YTD
-15.99%
QTD
-6.86%
Financial performance
How have Treace Medical Concepts's revenue and profit performed over time
Revenue
$213.75M
Gross profit
$171.25M
Operating income
-$47.89M
Net income
-$49.18M
Gross margin
80.1%
Net margin
-23%
The operating margin is up by 31% YoY and by 10% QoQ
TMCI's net margin is up by 28% YoY and by 8% QoQ
The operating income has grown by 26% YoY and by 8% from the previous quarter
The company's net income rose by 23% YoY and by 7% QoQ
Price vs fundamentals
How does TMCI's price correlate with its fundamentals
Growth
What is Treace Medical Concepts's growth rate over time
Valuation
What is Treace Medical Concepts stock price valuation
P/E
N/A
P/B
4.03
P/S
1.84
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.12
The EPS is up by 23% year-on-year and by 7% since the previous quarter
TMCI's P/B is 58% below its 5-year quarterly average of 9.6
The equity has declined by 13% year-on-year and by 7% since the previous quarter
The P/S is 75% below the 5-year quarterly average of 7.3 and 12% below the last 4 quarters average of 2.1
TMCI's revenue is up by 8% YoY
Efficiency
How efficient is Treace Medical Concepts business performance
The return on sales is up by 30% year-on-year and by 9% since the previous quarter
Treace Medical Concepts's return on invested capital has increased by 16% YoY and by 7% QoQ
Treace Medical Concepts's ROA has increased by 12% YoY and by 4.9% from the previous quarter
The return on equity has increased by 5% year-on-year and by 3.9% since the previous quarter
Dividends
What is TMCI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TMCI.
Financial health
How did Treace Medical Concepts financials performed over time
TMCI's total assets is 90% greater than its total liabilities
Treace Medical Concepts's quick ratio has decreased by 26% QoQ and by 12% YoY
Treace Medical Concepts's current ratio has decreased by 22% from the previous quarter and by 9% YoY
TMCI's debt is 31% lower than its equity
The equity has declined by 13% year-on-year and by 7% since the previous quarter
The debt to equity has grown by 11% YoY and by 8% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.